11
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2342 | Raxatrigine | CNV1014802,CNV 1014802,GSK-1014802,CNV-1014802 | Sodium Channel |
Raxatrigine (CNV 1014802) has been investigated for the treatment of Bipolar Disorder and Bipolar Depression. | |||
T41192 | CNV Dopamine | ||
CNV Dopamine is a carboxynitroveratryl (CNV)-caged dopamine; releases dopamine upon ultraviolet light stimulation (365 nm). Induces dopaminergic currents upon photolysis in brain slices expressing wild-type or GFP-labele... | |||
T71239 | CNV-2197944 | ||
CNV-2197944 is a novel, small molecule, state-dependent calcium channel blocker, designed to selectively inhibit highly active Cav2.2 channels. | |||
T2141 | Mecamylamine hydrochloride | Inversine,Mevasin | AChR |
Mecamylamine hydrochloride (Mevasin) is a nicotinic antagonist, used as a ganglionic blocker in hypertension. | |||
T71237 | SC 46944 | ||
SC 46944 is a highly potent human renin inhibitor. | |||
T14992 | Raxatrigine hydrochloride | GSK-1014802 hydrochloride,CNV1014802 (hydrochloride) | Others |
Raxatrigine hydrochloride is a state-dependent sodium channel blocker and a Nav1.7 sodium channel inhibitor. | |||
T80459 | ω-Conotoxin CnVIIA | Calcium Channel | |
ω-Conotoxin CnVIIA, a 27-amino-acid neuropeptide toxin, serves as an N-type calcium current blocker [1]. | |||
T67746 | IMS2186 | Others | |
IMS2186 is a reagent with activity of antichoroidal neovascularization (CNV). IMS2186 could arrest cancer cell cycle in G2/M phase, result in exerting anti-proliferation and anti-angiogenesis effects. IMS2186 reduces the... | |||
T70329 | SH-11037 | ||
SH-11037 is a novel potent seh inhibitor, effectively blocking key angiogenic properties of human retinal endothelial cells (hrecs), inhibiting choroidal sprouting and significantly suppressing cnv lesion volume | |||
T75156L | Bevasiranib sodium | ||
Bevasiranib sodium, an siRNA compound, targets and silences the genes responsible for producing vascular endothelial growth factor (VEGF). The suppression of VEGF, a critical factor in the development of choroidal neo-va... | |||
T75156 | Bevasiranib | ||
Bevasiranib, a siRNA, is specifically engineered to suppress the expression of genes responsible for the production of vascular endothelial growth factor (VEGF), a critical factor in the development of choroidal neo-vasc... |